Recent Publications and Grants

Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.

Recent Publications

Research Grants

  • NIH/NIAID (Morse) HIV/AIDS Clinical Trial Unit. Andrew Talal (Co-Principal Investigator). 12/1/2013-4/1/2028.
  • A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration. John Sullivan (Principal Investigator). VA Central Office. $330,000. 1/1/2025-12/1/2027.
  • Exercise Reset for Concussion - Modifying the Buffalo Concussion Protocol for Application in a Military Environment. John Leddy (Principal Investigator). Department of Defense (CDMRP). 1/1/2023-12/1/2027.
  • Modulation of oligodendrocyte development by voltage-operated calcium channels. Pablo Paez (Principal Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $1,993,750. 12/1/2021-11/1/2027.
  • Center for Advanced Technology in Big Data and Health Sciences. Norma Nowak (Principal Investigator). New York State Department of Empire State Development. $9,200,000. 7/1/2017-6/1/2027.
  • Molecular mechanisms of skin immunity to Staphylococcal infection. Lee Ann Garrett-Sinha (Co-Principal Investigator). NIH. $527,503. 7/1/2022-6/1/2027.
  • The role of the nociceptor endocytosis in inflammatory pain. Arin Bhattacharjee (Principal Investigator). National Institute of Neurological Disorders & Stroke. $1,907,471. 6/1/2022-5/1/2027.
  • T Regulatory cell responses in Toxoplasma-infected muscle. Elizabeth Wohlfert (Principal Investigator). NIAID/NIH. $2,445,371. 2/1/2022-3/1/2027.
  • A Multicenter Randomized Controlled Trial of Best Available Therapy versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis, BEAT-MS (Protocol ITN077AI). Bianca Weinstock-Guttman (Principal Investigator). National Institute of Allergy & Infectious Diseases (NIAID), Division of Allergy, Immunology &Transplantation (DAIT) via a subaward. 1/1/2020-12/1/2026.
  • Impacts of Nicotinamide Riboside on functional capacity and muscle physiology in older veterans. Nikhil Satchidanand (Co-Investigator). Veterans Affairs. 1/1/2022-12/1/2026.
  • Immunomodulatory Therapy After Resuscitation From Cardiac Arrest. Olga Pletnikova (Consultant). NIH. 1/1/2022-12/1/2026.
  • MARCH proteins, members of a host protein family that targets HIV. Spyridon Stavrou (Principal Investigator). NIH/NIAID. $1,974,920. 12/1/2021-11/1/2026.
  • Effects of mesolimbic amylin signaling on macronutrient intake. Jinwoo Park (Co-Investigator). NIH/NIDDK. $2,202,189. 12/1/2021-11/1/2026.
  • Tonawanda Coke Environmental Health Study. Laurene Tumiel Berhalter (Co-Investigator). US District Court for the Western District of New York. $11,100. 9/1/2016-9/1/2026.
  • The Tonawanda Health Study: An Epidemiologic Study of Health Effects and Coke Oven Emissions from Tonawanda Coke. James Olson (Co-Investigator). US Attorney’s Office, Department of Justice, Tonawanda Coke Corp. $7,933,256. 9/1/2016-9/1/2026.